Literature DB >> 12849813

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.

Veysel Fenkci1, Semin Fenkci, Mehmet Yilmazer, Mustafa Serteser.   

Abstract

OBJECTIVE: To determine oxidative stress by the level of protein carbonyls and total antioxidant status (TAOS), and whether oxidative stress is associated with increased risk of cardiovascular disease in women with polycystic ovary syndrome (PCOS).
DESIGN: Controlled clinical study.
SETTING: University hospital. PATIENT(S): Thirty women with PCOS and 31 healthy control women. INTERVENTION(S): Biometric measures and blood samples collection. MAIN OUTCOME MEASURE(S): C-reactive protein (CRP), lipid fractions, glucose, protein carbonyls, insulin, and other hormone (gonadotropins, androgens) levels and TAOS were measured. The estimate of insulin resistance was calculated by homeostasis model assessment (HOMA-R). RESULT(S): The women with PCOS had significantly higher serum fasting insulin, CRP, protein carbonyl levels, HOMA-R, LH levels, and LH/FSH ratios than healthy women. However, TAOS was significantly lower in women with PCOS. TAOS was negatively correlated with fasting insulin, HOMA-R, CRP, and protein carbonyls. Fasting insulin was positively correlated with protein carbonyls. High density lipoprotein (HDL) was inversely associated with fasting insulin, HOMA-R, and protein carbonyls. CONCLUSION(S): Increased oxidative stress and decreased antioxidant capacity may contribute to the increased risk of cardiovascular disease in women with PCOS, in addition to known risk factors such as insulin resistance, hypertension, central obesity, and dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849813     DOI: 10.1016/s0015-0282(03)00571-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  66 in total

1.  The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.

Authors:  J R Palacio; A Iborra; Z Ulcova-Gallova; R Badia; P Martínez
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Antioxidants induce apoptosis of rat ovarian theca-interstitial cells.

Authors:  Izabela J Rzepczynska; Nastaran Foyouzi; Piotr C Piotrowski; Ciler Celik-Ozenci; Amanda Cress; Antoni J Duleba
Journal:  Biol Reprod       Date:  2010-09-15       Impact factor: 4.285

Review 3.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

4.  Benefits of omega-3 Fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome.

Authors:  Elahe Mohammadi; Maryam Rafraf
Journal:  Health Promot Perspect       Date:  2012-12-28

5.  Changes in the Lipid Peroxidation-Antioxidant Protection System in Women with Ovarian Hyperandrogenism at Different Periods of Reproductive Age.

Authors:  L I Kolesnikova; O V Krusko; L V Belenkaya; L F Sholokhov; L A Grebenkina; N A Kurashova; S I Kolesnikov
Journal:  Bull Exp Biol Med       Date:  2021-01-16       Impact factor: 0.804

Review 6.  Could oxidative stress influence the in-vitro maturation of oocytes?

Authors:  Catherine M H Combelles; Sajal Gupta; Ashok Agarwal
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

Review 7.  Oxidative stress and antioxidants: exposure and impact on female fertility.

Authors:  Elizabeth H Ruder; Terryl J Hartman; Jeffrey Blumberg; Marlene B Goldman
Journal:  Hum Reprod Update       Date:  2008-06-04       Impact factor: 15.610

8.  Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome.

Authors:  Frank González; John P Kirwan; Neal S Rote; Judi Minium
Journal:  Am J Obstet Gynecol       Date:  2014-06-20       Impact factor: 8.661

9.  Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Marguerite K Shepard; Neal S Rote; Judi Minium
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

10.  Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with polycystic ovary syndrome.

Authors:  A Masha; C Manieri; S Dinatale; G A Bruno; E Ghigo; V Martina
Journal:  J Endocrinol Invest       Date:  2009-04-15       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.